Skip to main
MCS

Marcus (MCS) Stock Forecast & Price Target

Marcus (MCS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Marcus is well positioned fundamentally because its theatres business is benefiting from a stronger, more consistent film slate, evidenced by first-quarter revenues of $154.4 million, admissions up 9.8%, same-store attendance up 1.9%, and average ticket prices rising 7.8% year over year. Hotel demand also remains supportive despite a choppier macro backdrop, while property ownership gives operating flexibility and potential real-estate monetization, and the company’s strong balance sheet supports capital returns and M&A optionality. With capex set to drop to $50–55 million in 2026 from $83 million in 2025, Marcus should see stronger free cash flow, helping consolidate growth across both segments.

Bears say

Marcus is exposed to a fragile operating backdrop in which weak macroeconomic conditions and softer consumer confidence can pressure discretionary spending on movies and travel, both of which are important to its theaters and hotels businesses. Its largest revenue source, the theaters segment, faces uncertain box office performance and secular shifts in how movies are watched, which may erode attendance and limit recovery in a business already sensitive to demand trends. In addition, labor cost and availability pressures, together with financial leverage, increase operating risk and could constrain profitability and flexibility if revenue growth fails to offset these headwinds.

Marcus (MCS) has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Marcus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Marcus (MCS) Forecast

Analysts have given Marcus (MCS) a Buy based on their latest research and market trends.

According to 4 analysts, Marcus (MCS) has a Buy consensus rating as of Oct 7, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $30.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $30.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Marcus (MCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.